Author response to: Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials
- PMID: 39178175
- PMCID: PMC11342962
- DOI: 10.1093/bjs/znae211
Author response to: Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials
Comment on
-
Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.Br J Surg. 2024 Aug 2;111(8):znae209. doi: 10.1093/bjs/znae209. Br J Surg. 2024. PMID: 39166496 Free PMC article. No abstract available.
References
-
- Donnelly M, Ryan OK, Ryan ÉJ, Creavin B, O’Reilly M, McDermott Ret al. Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials. Br J Surg 2023;110:1316–1330 - PubMed
-
- Erlandsson J, Holm T, Pettersson D, Berglund Å, Cedermark B, Radu Cet al. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol 2017;18:336–346 - PubMed
-
- Dijkstra EA, Nilsson PJ, Hospers GAP, Bahadoer RR, Meershoek-Klein Kranenbarg E, Roodvoets AGHet al. Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO trial. Ann Surg 2023;278:e766–e772 - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
